BrainsWay (BWAY:NASDAQ) Annual Reports & Investor Relations Material

Overview

Jerusalem-based Brainsway Ltd. is at the forefront of developing and selling advanced noninvasive neurostimulation treatments that are geared towards mental health disorders. Boasting a global presence, the company offers cutting-edge Deep Transcranial Magnetic Stimulation platform technology that targets a broad range of conditions that range from major depressive disorders, anxious depression, and obsessive-compulsive disorders, to smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. With an impressive customer base that includes doctors, hospitals, and medical centers in psychiatry, Brainsway Ltd. continues to be a trailblazer in the field of mental health treatment since its founding in 2003.

Frequently Asked Questions

What is BrainsWay's ticker?

BrainsWay's ticker is BWAY

What exchange is BrainsWay traded on?

The company's shares trade on the NASDAQ stock exchange

Where are BrainsWay's headquarters?

They are based in Jerusalem, Israel

How many employees does BrainsWay have?

There are 51-200 employees working at BrainsWay

What is BrainsWay's website?

It is brainsway.com

What type of sector is BrainsWay?

BrainsWay is in the Healthcare sector

What type of industry is BrainsWay?

BrainsWay is in the Medical Appliances & Equipment industry

Who are BrainsWay's peers and competitors?

The following five companies are BrainsWay's industry peers:

- ConforMIS

- Cochlear

- CHF Solutions, Inc.

- Medical Facilities Corporation

- Natus Medical